Dr Dainis Krievins is a Director of Institute of Research and Chief of Endovascular Program at Pauls Stradins Clinical university hospital. He has been a board-certified vascular surgeon since 1998.
Dr Krievins serves as the President of the Latvian Society of Vascular Surgery since 2012 and he is a Professor of Vascular Surgery at University of Latvia. In addition, he is co-founder and Executive Chairman of Scientific Advisory Board of Clinical Research Foundation EEU.
Dr Krievins’ special interest has been development of new vascular devices. He served as a principal investigator for numerous FIM and CE mark/FDA clinical trials. His academic research focuses on the process of innovation for development of novel medical technologies to treat aneurysms and peripheral arteries.
Dr Krievins graduated in 1993 from the Medical Academy of Latvia and he completed his residency of Surgery and Vacular Surgery at Riga Stradins University. He completed Vascular Surgery Fellowship at Stanford University Medical Center.
Dr Mastracci is a vascular surgeon with an interest in complex aortic repair. She completed general and vascular surgery training at McMaster University in Hamilton, Ontario, Canada, and moved on to a superfellowship in complex aortic repair at the Cleveland Clinic in Cleveland, Ohio. Dr Mastracci’s first consultant position was at the Cleveland Clinic, where she also held a position as assistant professor at Case Western Reserve University for seven years. Dr Mastracci moved to the Royal Free London in October 2014 to lead the aortic team.
Dr Mastracci is a clinical epidemiologist by training and focuses most of her research in clinical outcomes related to disease of the aorta. She has a specific interest in endovascular aneurysm repair, stent graft design and development, the genetics of aortic disease, and the advancement of new intraoperative imaging techniques. Recently Dr Mastracci has partnered with the radiation physics department at the Royal Free Hospital to improve radiation safety in the field of vascular surgery.
Dr Peter Schneider received his degree from the Johns Hopkins University School of Medicine in Baltimore, Maryland. He completed his internship, residency, and fellowship at the University of California San Francisco (UCSF) Medical Center as well as a fellowship at the Scripps Clinic and Research Foundation in La Jolla, California.
At the Hawaii Permanente Medical Group (HPMG), Dr Schneider is the chief of the division of vascular therapy and Director of New Ventures. In recent years, he has served as co-chair of the organizing committee of the 9th Hawaii Vascular Symposium, and he moderated a session on peripheral vascular disease at the UCSF Vascular Symposium. At the Vascular Interventional Advances conference in Las Vegas, Dr Schneider was part of a team of HPMG vascular surgeons that performed cases via satellite for conference attendees. They had the privilege to share best practices for the care of patients with vascular disease, and to highlight the quality care Hawaii has to offer. The HPMG group started a fellowship for doctors from other hospitals to improve their skills in minimally invasive vascular repair. They have a very busy clinical research program with several clinical trials going on at once. The HPMG group publishes two to four scientific research articles per year. Dr Schneider has also published a textbook in vascular surgery which is widely used in the U.S. and abroad. He serves on the editorial board of Vascular Disease Management, Annals of Vascular Surgery, and Endovascular Today. In recent years, he has been a visiting professor at Beijing University, the University of Massachusetts Medical Center, the University of British Columbia, Oregon Health Sciences University, University of Kansas (McEwen Visiting Professorship), Boston University School of Medicine, Stanford University School of Medicine, and elsewhere. Dr Schneider is board certified in vascular surgery by the American Board of Surgery, and a fellow of the American College of Surgeons, the Society for Vascular Surgery, and the International Society of Vascular Surgery. He is a member of the Western Vascular Society, the Society for Clinical Vascular Surgery, the American Heart Association, the International Society for Endovascular Specialists, the Nafzigger Surgical Society, and the Johns Hopkins Medical and Surgical Association.
Dr Schneider enjoys being involved in the community in his free time. He was on the board of directors of Network Enterprises, a non-profit corporation that employs handicapped workers, and has also served as their Vice Chairman.